The global ocular inflammation treatment market is poised for steady growth over the coming years, driven by rising environmental concerns, increasing prevalence of eye infections, and advancements in pharmaceutical research. Valued at US$ 412.3 Mn in 2022, the market is projected to reach US$ 696.5 Mn by the end of 2031, expanding at a CAGR of 6.1% from 2023 to 2031. Ocular inflammation,...